Updated Jul 16, 2026
Crombez Eric has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $429K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-15 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 26.1K | $5.53 | $145K |
| 2026-05-06 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 344 | $24.96 | $9K |
| 2026-04-20 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 34.7K | $0.00 | |
| 2026-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | S — Open-market sale | 7.0K | $22.80 | $160K |
| 2026-03-03 | RARE | Ultragenyx Pharmaceutical Inc. | A — Grant or award | 11.6K | $0.00 | |
| 2026-02-02 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 16.3K | $5.09 | $83K |
| 2026-01-27 | ABEO | ABEONA THERAPEUTICS INC. | A — Grant or award | 37.3K | $0.00 | |
| 2025-08-14 | ABEO | ABEONA THERAPEUTICS INC. | S — Open-market sale | 4.7K | $6.93 | $33K |
Crombez Eric is a corporate insider — currently tracked as Director of ABEONA THERAPEUTICS INC. (ABEO). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($429K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Crombez Eric profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.